ArticleJournal of biomolecular structure & dynamics2022

Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study.

Prateek Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.